Case Report: Late Hypersensitivity Reaction to Hydroxyurea in a Patient With Myeloproliferative Disorder

Navkirat Kahlon1, Sujatha Baddam2, Harinderjeet Kaur3

  • 1Department of Medical Oncology, Mass General Cancer Center at Wentworth-Douglass Hospital, Dover, New Hampshire, USA.

PubMed
Summary

Hydroxyurea, a key treatment for myelofibrosis, can cause rare hypersensitivity reactions. This case shows that discontinuing hydroxyurea and switching to ruxolitinib resolved symptoms, highlighting the need for careful management.